🇺🇸 Methotrexate therapy in United States
2 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 2
Most-reported reactions
- Breast Cancer — 1 report (50%)
- Drug Ineffective — 1 report (50%)
Frequently asked questions
Is Methotrexate therapy approved in United States?
Methotrexate therapy does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Methotrexate therapy in United States?
National Medical Research Center for Children's Health, Russian Federation is the originator. The local marketing authorisation holder may differ — check the official source linked above.